TGF-β1: Immunosuppressant and viability factor for T lymphocytes

Microbes and Infection

Volumn 1, Issue 15, 1999, Pages 1291-1296

  Cerwenka, Adelheid ^a   Swain, Susan L ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

Immunosuppression; T lymphocyte; TGF ; Viability

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTATION; ARTICLE; CELL VIABILITY; CYTOKINE RELEASE; HUMAN; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; ANIMAL; DRUG EFFECT; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNOSUPPRESSION; MICE; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033233253     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00255-5     Document Type: Review

References (45)

1. Wahl S.M. Transforming growth factor-β. The good the bad the ugly. J. Exp. M. 180:1994;1587-1590.
2. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β Annu. Rev. Immunol. 16:1998;137-161.
3. Kehrl J.H., Roberts A.B., Wakefield L.M., Jalowlew S., Sporn M.B., Fauci S. Transforming growth factor is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:1986;3855-3860.
4. Mc Cartney-Francis N., Mizel D., Wong H., Wahl L., Wahl S. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors. 4:1990;27-35.
5. Celada A., Maki R.A. Transforming growth factor-β enhances the m-CSF and GM-CSF-stimulated proliferation of macrophages. J. Immunol. 148:1992;1102-1105.
6. Strobl H., Riedl E., Scheinecker C., Pickl W.F., Rappersberger K., Majdic Oknapp W. TGF-beta1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 157:1996;1499-1507.
7. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M.B., Fauci A.S. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. M. 163:1986;1037-1050.
8. Seder R.A., Marth T., Sieve M.C., Strober W., Letterio J.J., Roberts A.B., Kelsall B. Factors involved in the differentiation of TGF-β-producing cells from naive CD4 T cells IL-4 and IFN-γ have opposing effects while TGF-β positively regulates its own production. J. Immunol. 160:1998;5719-5728.
9. Assoian R.K., Komoryia A., Meyers C.A., Miller D.M., Sporn M.B. Transforming growth factor β in human platelets Identification of a major storage site purification and characterization. J. Biol. Chem. 258:1983;7155-7160.
10. O' Connor-Mccourt M.D., Wakefield D.M. Latent TGF-β in human serum. J. Biol. Chem. 262:1987;14090.
11. Cerwenka A., Bevec D., Majdic O., Knapp W., Holter W. TGF-β1 is a potent inducer of human effector T cells. J. Immunol. 153:1994;4367-4377.
12. Cerwenka A., Kovar H., Majdic O., Holter W. Fas-and activation induced apoptosis are reduced in human T cells preactivated in the presence of TGF-β1. J. Immunol. 156:1996;459-464.
13. Chen W., Jin W., Wahl S.M. Engagement of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+T cells. J. Exp. M. 188:1998;1849-1857.
14. Miyazono K., Hellman U., Wernstedt C., Heldin C.H. Latent high molecular weight complex of transforming growth factor β J. Biol. Chem. 263:1988;6407-6415.
15. Swain S.L., Huston G., Tonkonogy S., Weinberg A. Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:1991;2991-3000.
16. Rich S., Seelig M., Lee H., Lin J. Transforming growth factor β1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells. J. Immunol. 155:1995;609-618.
17. Marth T., Strober W., Kelsall B.L. High dose oral tolerance in ovalbumin TCR-transgenic mice. J. Immunol. 157:1996;2348-2357.
18. Gorham J.D., Gueler M.L., Fenoglio D., Gubler U., Murphy K.M. Low dose TGF-β1 attenuates IL-12 responsiveness in murine Th cells. J. Immunol. 161:1998;1664-1670.
19. De Jong R., VanLier R.A.W., Ruscetti F.W., Schmitt C., Debre D., Mossalayi M.D. Differential effect of transforming growth factor-β1 on the activation of human naive and memory CD4+ T lymphocytes. Int. Immunol. 6:1994;631-638.
20. Ranges G.E., Figari I.S., Espevik T., Palladino M.A. Inhibition of cytotoxic T cell development by transforming growth factor-β and reversal by tumor necrosis factor-α J. Exp. M. 166:1987;991-998.
21. Pardoux C., Asselin-Paturel C., Chehimi J., Gay F., Mami-Chouaib F., Chouaib S. Functional interaction between TGF-β and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J. Immunol. 158:1997;136-143.
22. + T lymphocytes. J. Immunol. 146:1991;3289-3297.
23. Inge T.H., McCoy T.M., Susskind B.M., Barrett S.K., Zhao G., Bear H.D. Immunomodulatory effects of transforming growth factor-β on T lymphocytes. J. Immunol. 148:1992;3847-3856.
24. Espevik T., Figari I.S., Shalaby M.R., Lackides G.A., Lewis G.D., Shepard H.M., Palladino M.A. Inhibition of cytokine production by cyclosporin A and transforming growth factor β J. Exp. M. 166:1987;571-576.
25. Holter W., Kalthoff F.S., Pickl W.F., Ebner C., Majdic O., Kraft D., Knapp W. Transforming growth factor-β inhibits IL-4 and IFN-γ production by stimulated human T cells. Int. Immunol. 6:1994;469-475.
26. Fargeas C., Wu C.Y., Nakajima T., Cox D., Nutman T., Delespesse G. Differential effect of TGF-β on the synthesis of Th1 and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 22:1992;2173-2176.
27. Waterhouse P., Penninger J., Timms E., Wakeham A., Shahinian A., Lee K., Thompson C., Griesser H., Mak T.W. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science. 270:1995;985-988.
28. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel B., Calvin D. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
29. Laiho M., Decaprio J.A., Ludlow J.W., Livingstone D.M., Massague J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell. 62:1990;175-185.
30. Zhang X., Giangreco L., Broome H.E., Dargan C.M., Swain S.L. Control of CD4 effector fate transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. M. 182:1995;699-709.
31. Bright J.J., Kerr L.D., Sriram S. TGF-β1 inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat-5 in T lymphocytes. J. Immunol. 159:1997;175-183.
32. Lee H., Rich S. Co-stimulation of T cell proliferation by transforming growth factor-β1. J. Immunol. 147:1991;1127-1133.
33. Lee H.M., Rich S. Differential activation of CD8+ T cells by Transforming Growth Factor-beta 1. J. Immunol. 151:1993;668-677.
34. Rich S., VanNood N., Lee H.M. Role of α5β1 integrin in TGF-β1-costimulated CD8+T cell growth and apoptosis. J. Immunol. 157:1996;2916-2933.
35. Swain S.L., Croft M., Dubey C., Haynes L., Rogers P., Zhang X., Bradley L.M. From naive to memory T cells. Immunol. Rev. 150:1996;143-167.
36. Klas C., Debatin K., Jonker R.R., Krammer P.H. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:1993;625-630.
37. Genestier L., Brunner T., Kasibhatla S., Green D.R. Transforming growth factor-β1 inhibits fas ligand expression and subsequent activation induced cell death in T cells via downregulation of c-myc. J. Exp. M. 189:1999;231-239.
38. Sad S., Mosmann T.R. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:1994;3514-3522.
39. Swain S.L. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity. 1:1994;543-552.
40. Barral-Netto M., Barral A., Brownell Y., Skeiky A.W., Ellingsworth L.R., Twardzig D.R., Reed S.G. Transforming growth factor in leishmania infection a parasite escape mechanism. Science. 257:1992;545-548.
41. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
42. Neurath M.F., Fuss I., Kelsall B.L., Persky D.H., Waegell W., Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. M. 183:1996;2605-2616.
43. Prowie F., Carlino J., Leach M.W., Mauze S., Coffman R.L. A critical role of transforming growth factor-β but not IL-4 in the suppression of T helper type 1-mediated colitis by CD45RB low CD4+T cells. J. Exp. M. 183:1996;2669-2674.
44. King C., Davies J., Mueller R., Lee M., Krahl T., Yeung B., O'Connor E., Sarvetnick N. TGF-β1 alters APC preference polarizing islet antigen repsonse toward a Th2 phenotype. Immunity. 8:1998;601-613.
45. Moses H.L., Yang E.Y., Pietenpol J.A. TGF-β stimulation and inhibition of cell proliferation. New mechanistic insights. Cell. 63:1992;245-247.